Sign in

    Gohealth Inc (GOCO)

    You might also like

    GoHealth, Inc. is a leading health insurance marketplace and Medicare-focused digital health company. It leverages a proprietary technology platform to optimize the process of helping individuals find the best health insurance plan tailored to their specific needs. The company sells a wide selection of health plans, focusing on Medicare products and individual and family plans.

    1. Medicare—Internal - Focuses on sales of Medicare Advantage, Medicare Supplement, Medicare Prescription Drug Plans, and Medicare Special Needs Plans through GoHealth-employed agents or its online platform.
    2. Medicare—External - Represents sales of Medicare products through an independent, national network of agents using GoHealth's platform to enroll consumers.
    3. Individual and Family Plans (IFP) and Other—Internal - Focuses on sales of individual and family plans, dental plans, vision plans, and other ancillary plans to individuals not eligible for Medicare.
    4. IFP and Other—External - Similar to the internal IFP segment but utilizes external agents for sales.
    NamePositionExternal RolesShort Bio

    Vijay Kotte

    ExecutiveBoard

    Chief Executive Officer (CEO)

    CEO of GoHealth, Inc. since 2022 and a member of the Board of Directors, known for his leadership in innovative healthcare models.

    View Report →

    Brad Burd

    Executive

    Chief Legal Officer and Corporate Secretary

    Brad Burd has served as GoHealth's Chief Legal Officer and Corporate Secretary since February 2024, after serving as General Counsel from 2011 until his promotion in February 2024. He played a key role during the company's IPO in 2020.

    Brendan Shanahan

    Executive

    Chief Financial Officer (CFO)

    Brendan Shanahan is the Chief Financial Officer (CFO) of GOCO since October 14, 2024 and is responsible for financial strategy and operations. Previously, he held executive roles at UpStream Care Company and Cedar Gate Technologies.

    Michael Hargis

    Executive

    Chief Operating Officer

    Michael Hargis is the Chief Operating Officer of GoHealth since July 31, 2023, having previously served as Chief Customer Experience Officer from 2022.

    Abhiraj Modi

    Board

    Class II Director on the Board of Directors

    Managing Director at Centerbridge Partners; Board Member at Cascade Financial Holdings LLC

    Abhiraj Modi serves as the Class II Director on the Board at GOCO since July 9, 2024, having been nominated as the designee of Centerbridge Partners. He brings extensive industry experience through his role as Managing Director at Centerbridge Partners and his board membership at Cascade Financial Holdings LLC.

    Alan Wheatley

    Board

    Class II director

    Director and advisor to various healthcare companies

    Alan Wheatley has served as a Class II director of GOCO since July 9, 2024. He brings extensive healthcare experience from his prior role as President of Medicare and Medicaid at Humana Inc. from 1991 to 2022.

    Alexander E. Timm

    Board

    Director

    CEO and Board Member of Root, Inc.

    Alexander E. Timm has served as a Director on the Board of GoHealth, Inc. since 2020, leveraging his extensive insurance and corporate strategy experience. He also co-founded and has led Root, Inc. as CEO and Board Member since 2015.

    Brandon M. Cruz

    Board

    Co-Chairman of the Board of Directors

    Board member of HealthJoy, LLC; President of NVX Holdings, Inc.; Manager of BCCJ, LLC

    Brandon M. Cruz is the Co-Founder and Co-Chairman of the Board of Directors at GoHealth, Inc. since 2020, having helped guide the company through major strategic shifts. Previously, he served as Chief Strategy Officer and President, demonstrating his long-term commitment and leadership in the healthcare industry.

    Clinton P. Jones

    Board

    Co-Chairman of the Board

    Board member of Bridge Legal

    Clinton P. Jones is the co-founder of GoHealth, Inc. and served as its CEO from 2001 until 2022 before transitioning to his current role as Co-Chairman of the Board since 2020. He is also active externally as a board member at Bridge Legal.

    David Fisher

    Board

    Director

    CEO and President of Enova International, Inc ; Chairman of the Board of Directors of Enova International, Inc ; Director at FRISS ; Director at Fathom Digital Manufacturing Corp.

    David Fisher serves as Director and Chairperson of the Audit Committee at GOCO since 2022. He brings extensive leadership experience, including his active role as CEO and President of Enova International, Inc since 2013.

    Dr. Karoline H. Hilu

    Board

    Member of the Board of Directors

    Independent Director and Advisor at HealthJoy, LLC

    Dr. Karoline H. Hilu has served as an independent director at GOCO since January 5, 2023. She previously held executive roles including founding CEO of Emsana Health, Inc. from 2020 and Chief Strategy Officer at Crossover Health from 2015 to 2020.

    Jeremy W. Gelber

    Board

    Board of Directors Member

    Board Member at Civitas Solutions, Inc. (since 2019); Board Member at Remedi SeniorCare Holding Corporation (since 2019)

    Jeremy W. Gelber has served on GoHealth, Inc.'s Board of Directors since 2020 and on GoHealth Holdings, LLC's board of managers since 2019, leveraging his extensive healthcare investment expertise.

    1. Based on the Q&A where management discussed a disruptive 2024 AEP versus a potentially more stable 2025, how do you plan to differentiate your service offerings against competitors when market conditions stabilize, and what specific strategies will secure your market share?
    2. Given the limited guidance on free cash flow for 2025 and the emphasis on reactive investment based on market opportunities, can you clarify the metrics and conditions that will determine whether you prioritize debt reduction over reinvestment in technology and marketing?
    3. With Q4 2024 achieving a 27% reduction in direct operating cost per submission, what risks or external factors could threaten sustaining or further improving these cost efficiencies in upcoming quarters, and how do you plan to mitigate them?
    4. Your LTV models rely on historical persistency data amid significant plan exit disruptions in 2024; how will you adjust these models if the AEP sees improved persistency, and what impact could these changes have on your strategic investment decisions?
    5. Considering the mixed impact of initiatives like PlanFit Checkup and PlanFit Save during a highly disruptive AEP, what concrete steps and quantitative targets are being set to enhance their revenue or cost benefits in a less volatile market environment?

    Competitors mentioned in the company's latest 10K filing.

    CompanyDescription

    The company competes with this entity in the distribution of health insurance products using similar business models, including digital and telephonic platforms, for qualified prospects, sales, and health plan partner relationships.

    This entity is another competitor in the distribution of health insurance products, leveraging digital and telephonic platforms to find consumers interested in purchasing health insurance.

    CustomerRelationshipSegmentDetails

    United

    Commission-based, non-exclusive agency agreements

    All

    28.3% of total revenue in 2024, 20.0% in 2023, 18.4% in 2022.

    Humana

    Commission-based, non-exclusive agency agreements

    All

    25.1% of total revenue in 2024, 28.0% in 2023, 25.6% in 2022.

    Elevance

    Commission-based, non-exclusive agency agreements

    All

    17.5% of total revenue in 2024, 19.4% in 2023, 22.6% in 2022.

    Aetna

    Commission-based, non-exclusive agency agreements

    All

    10.7% of total revenue in 2024, 16.8% in 2023, 9.1% in 2022.

    Centene

    Commission-based, non-exclusive agency agreements

    All

    10.5% of total revenue in 2024, 8.1% in 2023, 11.4% in 2022.

    Notable M&A activity and strategic investments in the past 3 years.

    CompanyYearDetails

    e-TeleQuote Insurance, Inc.

    2024

    GoHealth completed the acquisition on September 30, 2024, by acquiring a 100% equity interest—with an initial 18.9% stake followed by an 81.1% transfer from the former parent without consideration—adding over $100 million in contract assets, $18 million in cash, and a $5 million investment in newly issued shares. The deal expanded GoHealth’s capabilities with nearly 400 licensed agents, achieved a $77.4 million gain on bargain purchase, and strategically strengthened its position in the Medicare insurance market through a rapid 30-day integration.

    Recent press releases and 8-K filings for GOCO.

    GoHealth Reports Strong Q4 2024 and FY 2024 Financial & Operational Performance
    GOCO
    Earnings
    Revenue Acceleration/Inflection
    Debt Issuance
    • Q4 2024 Highlights: Revenue reached $389.1M (up 41% YoY), with 481,445 submissions (up 67%) and a net income improvement of $60.3M; adjusted EBITDA climbed to $117.8M with a 107% improvement
    • Fiscal Year 2024 Performance: Revenue totaled $798.9M (up 9% YoY), with adjusted EBITDA increasing to $120.3M, alongside 1,016,182 submissions (up 23%) and a reported net loss of $7.3M
    • Enhanced Operational Efficiency: Medicare unit economics improved with customer acquisition costs dropping 27% from $688 to $501 and sales per submission falling from 957 to 804
    • Digital Engagement & Technology Integration: Integration of e-TeleQuote and 72% YoY growth in PlanFit Checkup initiatives underscored the company’s digital focus
    • Strengthened Financial Position: Successfully refinanced a $475M term loan facility maturing in 2029, reinforcing long-term growth prospects
    Feb 27, 2025, 12:00 AM
    [Kuehn Law Investigates GoHealth Fiduciary Matters]
    GOCO
    Legal Proceedings
    • Kuehn Law, PLLC is investigating whether certain officers and directors of GoHealth, Inc. (NASDAQ: GOCO) breached their fiduciary duties through potential self-dealing activities.
    • The firm invites long-term GOCO stockholders to contact them for a free consultation, covering all case costs with no fees for investors.
    Feb 18, 2025, 5:37 PM